These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 10845767)
1. Yohimbine in erectile dysfunction: the facts. Morales A Int J Impot Res; 2000 Mar; 12 Suppl 1():S70-74. PubMed ID: 10845767 [TBL] [Abstract][Full Text] [Related]
2. Yohimbine in erectile dysfunction: the facts. Morales A Int J Impot Res; 2000 Mar; 12(S1):S70-S74. PubMed ID: 10849568 [TBL] [Abstract][Full Text] [Related]
3. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed? Morales A World J Urol; 2001 Aug; 19(4):251-5. PubMed ID: 11550783 [TBL] [Abstract][Full Text] [Related]
4. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Guay AT; Spark RF; Jacobson J; Murray FT; Geisser ME Int J Impot Res; 2002 Feb; 14(1):25-31. PubMed ID: 11896474 [TBL] [Abstract][Full Text] [Related]
5. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options]. Sperling H; Lümmen G; Schneider T; Rübben H Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147 [TBL] [Abstract][Full Text] [Related]
6. The role of yohimbine for the treatment of erectile impotence. Sonda LP; Mazo R; Chancellor MB J Sex Marital Ther; 1990; 16(1):15-21. PubMed ID: 2370671 [TBL] [Abstract][Full Text] [Related]
7. Yohimbine in the treatment of erectile disorder. Riley AJ Br J Clin Pract; 1994; 48(3):133-6. PubMed ID: 8031688 [TBL] [Abstract][Full Text] [Related]
8. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Goldstein I Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction. Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum. Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133 [TBL] [Abstract][Full Text] [Related]
13. Oral and transcutaneous pharmacologic agents in the treatment of impotence. Morales A; Condra MS; Owen JE; Fenemore J; Surridge DH Urol Clin North Am; 1988 Feb; 15(1):87-93. PubMed ID: 3125645 [TBL] [Abstract][Full Text] [Related]
14. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin. Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of impotence. Malloy TR; Malkowicz B Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750 [TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Filippi S; Luconi M; Granchi S; Natali A; Tozzi P; Forti G; Ledda F; Maggi M Int J Impot Res; 2002 Aug; 14(4):295-307. PubMed ID: 12152120 [TBL] [Abstract][Full Text] [Related]
17. [The effect of yohimbine on sexual function]. Gorbov VG Urol Nefrol (Mosk); 1991; (4):74-6. PubMed ID: 1949423 [No Abstract] [Full Text] [Related]
18. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Ernst E; Pittler MH J Urol; 1998 Feb; 159(2):433-6. PubMed ID: 9649257 [TBL] [Abstract][Full Text] [Related]
19. Yohimbine can be the new promising therapy for erectile dysfunction in type 2 diabetics. Tanweer MS; Fatima A; Rahimnajjad MK J Pak Med Assoc; 2010 Nov; 60(11):980. PubMed ID: 21375213 [No Abstract] [Full Text] [Related]